Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 20/10/2006 |
Symbol | AML1 |
Location | 21q22.12 |
Name | sporadic myeloid and lymphoid leukemias |
Corresponding gene | RUNX1 |
Main clinical features |
|
Genetic determination | |
Related entries | FPDAML |
Function/system disorder | hematology |
Type | malignancy |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments | |
---|---|---|---|---|
translocation | t(8;21)(q22;q22)in AML M2 subtype, t(16;21)(q24;q22) (CBFB), t(3;21)(q26;q22) in myelodysplasia syndrome (EVI1, MDS1), t(12;21)(p13;q22)in acute lymphoblastic leukemia(ETV6), and others | |||
various types | sporadic point mutations in AML M0 subtype, MDS-AML, therapy-related MDS/AML | |||
amplification | in a subtype of ALL (iAMP21) |
Remark(s) | RUNX1(AML1) is one of the most frequent targets of chromosome translocations associated with leukemia |
Genotype/Phenotype correlations | germline mutations give rise to a familial platelet disoder with ppredisposition to acute myelogenous leukemia FPD/AML |